Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa

British Journal of Ophthalmology

Volumn 97, Issue 9, 2013, Pages 1187-1191

  Ikeda, Yasuhiro ^a   Yoshida, Noriko ^a   Notomi, Shoji ^a   Murakami, Yusuke ^a   Hisatomi, Toshio ^a   Enaida, Hiroshi ^a   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; LONG TERM CARE; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PERIMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA CYSTOID EDEMA; RETINITIS PIGMENTOSA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

RETINA;

ADMINISTRATION, TOPICAL; ADULT; ANTIHYPERTENSIVE AGENTS; CARBONIC ANHYDRASE INHIBITORS; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINITIS PIGMENTOSA; SULFONAMIDES; THIOPHENES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84882269142     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-303005     Document Type: Article

References (21)

1. Dryja TP, McGee TL, Reichel E, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990;343:364-6.
2. Kajiwara K, Hahn LB, Mukai S, et al. Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature 1991;354:480-3.
3. Cotran PR, Bruns GA, Berson EL, et al. Genetic analysis of patients with retinitis pigmentosa using a cloned cDNA probe for the human gamma subunit of cyclic GMP phosphodiesterase. Exp Eye Res 1991;53:557-64.
4. Pruett RC. Retinitis pigmentosa: clinical observations and correlations. Trans Am Ophthalmol Soc 1983;81:693-735.
5. Berson EL. Retinitis pigmentosa. The Friedenwald Lecture. Invest Ophthalmol Vis Sci 1993;34:1659-76.
6. Grover S, Fishman GA, Anderson RJ, et al. Rate of visual field loss in retinitis pigmentosa. Ophthalmology 1997;104:460-5.
7. Fishman GA, Maggiano JM, Fishman M. Foveal lesions seen in retinitis pigmentosa. Arch Ophthalmol 1977;95:1993-6.
8. Hirakawa H, Iijima H, Gohdo T, et al. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am J Ophthalmol 1999;128:185-91.
9. Hajali M, Fishman GA, Anderson RJ. The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. Br J Ophthalmol 2008;92:1065-8.
10. Cox SN, Hay E, Bird AC. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 1988;106:1190-5.
11. Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006;141:850-8.
12. Fishman GA, Apushkin MA. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Br J Ophthalmol 2007;91:743-5.
13. Genead MA, Fishman GA. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol 2010;128:1146-50.
14. Fishman GA, Gilbert LD, Fiscella RG, et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 1989;107:1445-52.
15. Fishman GA, Gilbert LD, Anderson RJ, et al. Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 1994;101:687-93.
16. Ikeda Y, Hisatomi T, Yoshida N, et al. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 2012;250:809-14.
17. Iijima H. Correlation between visual sensitivity loss and years affected for eyes with retinitis pigmentosa. Jpn J Ophthalmol 2012;56:224-9.
18. Saraiva VS, Sallum JM, Farah ME. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 2003;34:398-400.
19. Ozdemir H, Karacorlu M, Karacorlu S. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa. Acta Ophthalmol Scand 2005;83:248-51.
20. García-Arumí J, Martinez V, Sararols L, et al. Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa. Ophthalmology 2003;110:1164-9.
21. Yuzbasioglu E, Artunay O, Rasier R, et al. Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa. Curr Eye Res 2009;34:231-7.